Novo Nordisk Creates ‘App’ to Help Doctors Dose Insulin, Supporting New Trend in Diabetes Care
Novo Nordisk announced today the availability of NovoDoseâ¢â the first-ever mobile insulin dosing guide for physicians to look up dosing guidelines and blood glucose goals for their patients with diabetes, a disease that affects nearly 24 million Americans.